Skip to main content
. 2020 Sep 18;16(4):368–375. doi: 10.1159/000510061

Table 4.

Treatment-related adverse events

Adverse event (grade 3/4) NCT (n = 76), n (%) CT (n = 40), n (%)
Leukopenia 0 (0) 4 (10)
Trombocytopenia 0 (0) 0
Anemia 1 (1.3) 1 (2.5)
Hand-foot syndrome 0 (0) 1 (2.5)
Atrial fibrillation 0 (0) 1 (2.5)
Alanine aminotransferase increased 0 (0) 1 (2.5)
Oral mucositis 2 (2.6) 1 (2.5)
Myalgia, arthralgia 6 (7.9) 1 (5)
Hot flushes 23 (30.2) 11 (27.5)
Nausea 1 (1.3) 6 (15)